These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 15564396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.
    Bos C, Delmas Y, Desmoulière A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N.
    Radiology; 2004 Dec; 233(3):781-9. PubMed ID: 15486216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
    Frank JA, Zywicke H, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH, Bulte JW.
    Acad Radiol; 2002 Aug; 9 Suppl 2():S484-7. PubMed ID: 12188316
    [No Abstract] [Full Text] [Related]

  • 5. In vivo MR imaging of tissue-engineered human mesenchymal stem cells transplanted to mouse: a preliminary study.
    Ko IK, Song HT, Cho EJ, Lee ES, Huh YM, Suh JS.
    Ann Biomed Eng; 2007 Jan; 35(1):101-8. PubMed ID: 17111211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques.
    Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA.
    Transplantation; 2003 Oct 15; 76(7):1123-30. PubMed ID: 14557764
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pitfalls in employing superparamagnetic iron oxide particles for stem cell labelling and in vivo MRI tracking.
    Wang YX, Wang HH, Au DW, Zou BS, Teng LS.
    Br J Radiol; 2008 Dec 15; 81(972):987-8. PubMed ID: 19029055
    [No Abstract] [Full Text] [Related]

  • 10. Can we monitor cell therapy with MR imaging at clinical field strength after systemic injection?
    Clément O.
    Radiology; 2005 Jan 15; 234(1):3. PubMed ID: 15618365
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
    Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA.
    Radiology; 2003 Dec 15; 229(3):838-46. PubMed ID: 14657318
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.
    Terrovitis J, Stuber M, Youssef A, Preece S, Leppo M, Kizana E, Schär M, Gerstenblith G, Weiss RG, Marbán E, Abraham MR.
    Circulation; 2008 Mar 25; 117(12):1555-62. PubMed ID: 18332264
    [Abstract] [Full Text] [Related]

  • 13. Instant MR labeling of stem cells using magnetoelectroporation.
    Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW.
    Magn Reson Med; 2005 Oct 25; 54(4):769-74. PubMed ID: 16161115
    [Abstract] [Full Text] [Related]

  • 14. In vivo trafficking and targeted delivery of magnetically labeled stem cells.
    Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA.
    Hum Gene Ther; 2004 Apr 25; 15(4):351-60. PubMed ID: 15053860
    [Abstract] [Full Text] [Related]

  • 15. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging].
    Han JK, Kim SH.
    Korean J Hepatol; 2006 Mar 25; 12(1):116-9. PubMed ID: 16565614
    [No Abstract] [Full Text] [Related]

  • 16. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair.
    Kobayashi T, Ochi M, Yanada S, Ishikawa M, Adachi N, Deie M, Arihiro K.
    Arthroscopy; 2008 Jan 25; 24(1):69-76. PubMed ID: 18182205
    [Abstract] [Full Text] [Related]

  • 17. Splenosis: superparamagnetic iron oxide-enhanced MR imaging.
    Storm BL, Abbitt PL, Allen DA, Ros PR.
    AJR Am J Roentgenol; 1992 Aug 25; 159(2):333-5. PubMed ID: 1632350
    [No Abstract] [Full Text] [Related]

  • 18. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.
    Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H.
    Radiology; 2007 Aug 25; 244(2):514-23. PubMed ID: 17562811
    [Abstract] [Full Text] [Related]

  • 19. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
    Petersein J, Saini S, Weissleder R.
    Magn Reson Imaging Clin N Am; 1996 Feb 25; 4(1):53-60. PubMed ID: 8673716
    [Abstract] [Full Text] [Related]

  • 20. Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model.
    Bulte JW, Kostura L, Mackay A, Karmarkar PV, Izbudak I, Atalar E, Fritzges D, Rodriguez ER, Young RG, Marcelino M, Pittenger MF, Kraitchman DL.
    Acad Radiol; 2005 May 25; 12 Suppl 1():S2-6. PubMed ID: 16106536
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.